Primer: AIM Vaccine (6660 HK) - Aug 2026
AIM Vaccine is a leading, fully-integrated vaccine company in China, holding significant market shares in Hepatitis B and Rabies vaccines, but...
100 Views
Pre-IPO Chengdu Olymvax Biopharmaceuticals (A/H Lising) - Low Profitability Is a Pain Point
​Olymvax faces profit challenges due to low "gold content" in profits.Controlling shareholders’ reduction in holdings reflect their lack of...
275 Views
HK Connect Flows Weekly (Aug 22nd): China Life, Tencent, Alibaba, Kuaishou, AIA, Li Auto, Anta
We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for China Life, Tencent, Alibaba, Kuaishou, AIA, Li Auto,...
464 Views
HK Connect Flows Weekly (Aug 8th): Tencent, Kuaishou, Alibaba, Meituan, Li Auto, China Mobile
We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Tencent, Kuaishou, Alibaba, Meituan, Li Auto, China Mobile.
644 Views
Pre-IPO Ab&B Bio-Tech (PHIP Updates) - Some Points Worth the Attention
​Ab&B's performance has deteriorated due to product returns and inventory impairment.Intense competition/lacking R&D vision impact future...
599 Views